1. Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries.
- Author
-
Baussano I, Lazzarato F, Ronco G, Dillner J, and Franceschi S
- Subjects
- Adolescent, Age Factors, Child, Cost-Benefit Analysis, Developed Countries economics, Developing Countries economics, Female, Guinea epidemiology, Human papillomavirus 16 immunology, Human papillomavirus 18 immunology, Humans, Mass Vaccination, Papillomavirus Infections epidemiology, Papillomavirus Infections immunology, Papillomavirus Infections transmission, Poland epidemiology, Prevalence, Vaccination economics, Young Adult, Papillomavirus Infections prevention & control, Papillomavirus Vaccines administration & dosage, Papillomavirus Vaccines economics, Papillomavirus Vaccines immunology, Uterine Cervical Neoplasms epidemiology, Uterine Cervical Neoplasms prevention & control
- Abstract
Human papillomavirus (HPV) vaccination of a birth cohort of girls in the 9-13 age range is recommended as a priority, but decreases in HPV vaccine cost may make catch-up of a few additional cohorts more attractive not only in high-income countries. We assessed the reduction in HPV16 and 18 infections that could be achieved in a medium- (Poland) and a low-income (Guinea) country by adding one-time catch-up of 12- to 19-year-old girls to the vaccination of 11-year-old girls. According to our ad hoc adapted dynamic model of HPV infection transmission, the addition of catch-up was estimated to bring forward the 50% reduction of HPV16/18 prevalence due to vaccination in women ≤35 by as much as 5 years. Catch-up of 12- to 15-year olds reduced the cumulative probability of HPV16/18 infections by age 35 in the relevant cohorts by about 30% in both countries. Catch-up of 16- to 19-year-old girls added little. Regardless of the chosen catch-up strategy, 16 to 20% of HPV16/18 prevention from vaccination was attributable to herd immunity. Assuming a sufficiently low vaccine cost, the addition of a catch-up round is, therefore, worth considering in medium/low-income countries to extend vaccine benefits to less young adolescent girls whose future access to cervical screening is uncertain., (Copyright © 2013 UICC.)
- Published
- 2013
- Full Text
- View/download PDF